ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
GSK and Relation Therapeutics signed a deal worth up to $110 million for AI-driven drug discovery. The collaboration will use machine learning to identify new targets for diseases.
Tap to vote and see what everyone thinks.
Summary by ByteBrief